| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |